Optibrium extends StarDrop’s capabilities to guide the design of high
quality compound libraries for drug discovery
CAMBRIDGE, UK, 20th November 2012 – Optibrium™, developer of software
solutions for drug discovery, today announces a new version of its StarDrop™
platform. Version 5.3 introduces new features focused on the design of virtual
libraries, guided by StarDrop’s unique multi-parameter optimisation
capabilities to prioritise compounds with the best balance of properties for
synthesis and testing.
Version 5.3 introduces its virtual
library design capability as part of StarDrop’s Nova™ module, providing flexible
and easy scaffold-based enumeration of a virtual library to allow drug
discovery teams to rapidly explore new chemistry ideas. After drawing the
scaffold on which the library will be based, users can select multiple functional
groups, atoms or fragments to vary at each point of modification. These lists
may be selected from a user-defined or centrally managed library, or sketched
on an individual basis. A fully combinatorial library may be generated for
detailed investigation or, alternatively, a subset of compounds can be automatically
selected based on a predicted property or StarDrop’s unique Probabilistic
Scoring algorithm for multi-parameter optimisation.
These new capabilities are supported
by further enhancements to StarDrop’s core features, including easy-to-use
tools for clustering, filtering based on substructure or properties and
extensions to its interactive data visualisation. StarDrop offers a
comprehensive desktop environment that saves time and reduces costs in drug
discovery by guiding compound design and selection to quickly target high
quality chemistry. These include plug-in modules providing: rigorously
validated ADME QSAR models; quantum mechanical prediction of P450 metabolism;
automatic generation of robust QSAR models; compound idea generation; application
of 3D SAR based on Cresset’s™ Field technology; and the ability to integrate
seamlessly with other informatics and modelling platforms.
Matt Segall, CEO of Optibrium, commented,
“StarDrop offers a seamless workflow allowing our users to go from design and
enumeration of a virtual library, through property prediction to prioritising
the resulting compounds against the profile of properties they require for
their project objective. Supported by interactive visualisations in StarDrop’s
intuitive user interface, chemistry teams can quickly identify novel compounds
with a high chance of success.” Matt
goes onto explain, “Many of the enhancements to StarDrop come as a direct
result of working collaboratively with our users, which now include over 50
companies world-wide and seven of the top-ten pharma.”
For more information and to arrange a
free trial of StarDrop, visit www.optibrium.com, contact info@optibrium.com or call +44 01223 815900.
No comments:
Post a Comment